
Over the past week, Hyderabad news has carried reports of an alleged illegal egg-collection operation, and on 4 November 2026 the Telangana State Women's Commission issued notices and raised concern about hormone injections being given to women without proper medical care. The investigation is ongoing and no clinic has been named. One question many women are now asking is a medical one: what can go wrong when the ovaries are stimulated? The main risk to know about is ovarian hyperstimulation syndrome, or OHSS. This guide explains what it is, who is more likely to get it, which symptoms are normal after egg retrieval and which need a call to your clinic the same day.
The short answer
Ovarian hyperstimulation syndrome is an over-response of the ovaries to fertility medicines, usually seen in the days after egg retrieval. Most cases are mild and settle within one to two weeks. Severe OHSS is uncommon, and careful monitoring, individual dosing and the right choice of trigger injection lower the risk further. Severe tummy pain, breathlessness, vomiting or passing very little urine need urgent medical review.
What is ovarian hyperstimulation syndrome?
In IVF, hormone injections encourage several follicles (fluid-filled sacs that each hold an egg) to grow in the same cycle, instead of the single follicle of a natural month. In some women the ovaries respond very strongly. They enlarge, and blood vessels in and around them become leaky, so fluid moves out of the bloodstream into the abdomen. That fluid shift causes the bloating, discomfort and, in more serious cases, the breathlessness and low urine output that define OHSS.
The trigger for this reaction is the hormone hCG, either from the trigger injection given before egg collection or from an early pregnancy. That is why symptoms usually begin a few days after egg retrieval, and why they can last longer or start later if pregnancy happens in the same cycle.
How common is OHSS?
The Royal College of Obstetricians and Gynaecologists (RCOG) patient leaflet says mild OHSS affects up to 33 in 100 women having IVF, while moderate or severe OHSS affects just over 1 in 100. A 2026 NHS leaflet from Manchester University NHS Foundation Trust, quoting UK fertility regulator (HFEA) data, puts severe or critical OHSS at about 0.1% of UK IVF cycles. These are international figures, not MOM IVF data, but they show the pattern: mild symptoms are common, serious illness is rare.
| Level | What women usually notice | What usually happens |
|---|---|---|
| Mild | Bloating, a feeling of fullness, mild tummy ache, slight nausea | Rest, fluids and simple pain relief advised by the clinic; settles in days |
| Moderate | More swelling of the tummy, nausea or vomiting, an ultrasound may show fluid in the abdomen | Closer follow-up, blood tests and scans; most women are managed as outpatients |
| Severe | Severe pain, breathlessness, very little urine, rapid weight gain, feeling faint | Hospital care to monitor fluids, kidneys and the risk of blood clots |
Who is at higher risk of OHSS?
Doctors look for risk factors before stimulation starts, because prevention works far better than treatment. According to the RCOG and the American Society for Reproductive Medicine (ASRM), the risk is higher in women who:
- Have polycystic ovaries or polycystic ovary syndrome (PCOS)
- Are under 30 years of age
- Have a high AMH level or a high antral follicle count on scan, which signal a large egg reserve
- Have had OHSS before
- Develop many follicles or very high oestrogen levels during monitoring
- Become pregnant in the same treatment cycle
If you have PCOS, our article on PCOS and pregnancy explains why the ovaries in PCOS can respond so strongly to stimulation, and why dosing is often gentler.
How IVF teams lower the risk of OHSS
The ASRM published an updated guideline on preventing moderate and severe OHSS in 2023. Its main recommendations, which an experienced IVF team will discuss with you, include:
- A careful assessment before treatment. AMH, antral follicle count, age and past response help predict how strongly the ovaries may react.
- Individual medicine doses. Women at higher risk are usually started on a lower dose of stimulation medicine.
- An antagonist protocol. A GnRH antagonist protocol is recommended when OHSS is a concern, because it allows a different kind of trigger.
- A GnRH agonist trigger. For high responders, triggering egg maturation with a GnRH agonist instead of hCG greatly lowers the risk of early OHSS.
- Freezing all embryos. Delaying embryo transfer to a later cycle avoids the extra hCG of an early pregnancy, which is what drives late OHSS.
- Other medicines where suitable. Cabergoline or metformin may be used in selected women, as the doctor decides.
Close follicle tracking is part of this. During stimulation, regular ultrasound scans and hormone tests show how many follicles are growing and how fast, so the team can adjust doses or the plan in time. You can read how this monitoring fits into treatment on our fertility treatment page and in our step-by-step guide to the IVF process. If embryos are frozen for a later transfer, our page on embryo preservation explains what happens next.
Normal recovery after egg retrieval
Some discomfort after egg retrieval is expected and does not mean OHSS. Many women feel mild cramps, a little spotting and some bloating for a day or two. The ovaries are still larger than usual for a short while, so it is sensible to avoid strenuous exercise and heavy lifting until your clinic says otherwise.
Self-care that clinics commonly advise after egg collection
- Drink fluids regularly through the day, including oral rehydration drinks if advised.
- Rest, but keep gently moving around the house to help circulation.
- Use only the pain relief your clinic recommends.
- Weigh yourself each morning and note how much urine you pass, if your clinic asks you to.
- Avoid vigorous exercise and sexual intercourse until you are told it is safe.
Always follow the written instructions your own clinic gives you, as they are based on your response to treatment.
Warning signs: when to call your clinic straight away
The RCOG advises women to seek help quickly if symptoms get worse instead of better. Contact your IVF team or go to the nearest emergency department if you notice:
- Severe or worsening tummy pain or swelling
- Vomiting, or being unable to keep fluids down
- Passing much less urine than usual, or very dark urine
- Breathlessness, chest pain or a fast heartbeat
- Rapid weight gain over a day or two
- Pain or swelling in one leg, or sudden severe one-sided pelvic pain
Sudden one-sided pain can also be a sign of ovarian torsion, when an enlarged ovary twists. This is uncommon but needs emergency care, as the 2026 NHS leaflet points out.
How OHSS is treated
Most mild and moderate OHSS settles on its own as hormone levels fall, usually within seven to ten days if there is no pregnancy. Treatment supports the body while this happens: fluids, pain relief, anti-sickness medicine and regular checks of weight, urine, blood tests and scans. In severe cases women are admitted so fluids can be balanced, blood thinning injections may be given to lower the risk of clots, and sometimes excess fluid is drained from the abdomen with a fine needle. OHSS that happens alongside a pregnancy can last longer, so follow-up continues until symptoms clear.
Why medical supervision of egg collection matters
The current news reports are a reminder that ovarian stimulation is a medical treatment, not a simple procedure. Every woman who has her ovaries stimulated, whether for her own IVF, egg freezing or lawful egg donation, should have a medical assessment beforehand, regular scans during treatment, a doctor available afterwards and clear instructions on warning signs. In India, the ART (Regulation) Act, 2021 also requires written consent and registered clinics. If anyone suggests injections or egg collection outside a registered clinic, it is safest not to go ahead.
If you are planning IVF and want to understand your OHSS risk, ask about it at your fertility assessment. Questions worth asking include which protocol is planned for you, how often you will be scanned, which trigger injection is likely and whether a freeze-all approach might be advised.
Talk to us
If you are planning IVF and want to understand your own risk of OHSS before stimulation, our team can talk it through with you.
To book a consultation, call +91 98986 83636 (Monday to Saturday, 11 AM to 3 PM) or use the appointment form.
MOM IVF Fertility & Research Center Pvt. Ltd., 12-2-710, 1st & 2nd Floors, Beside Premier Hospital, Nanal Nagar X Roads, Mehdipatnam, Hyderabad, Telangana 500028.
Sources
- American Society for Reproductive Medicine. Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline, 2023.
- Royal College of Obstetricians and Gynaecologists. Ovarian hyperstimulation syndrome: patient information.
- Manchester University NHS Foundation Trust. Ovarian hyperstimulation syndrome patient leaflet, 2026.
- Hyderabad Mail. Telangana Women's Commission issues notices over Hyderabad egg racket, 4 November 2026.
- The Hindu. Oocyte extraction racket in Telangana, 2 November 2026.
This article is general health information and is not a substitute for a consultation. Treatment decisions depend on individual tests and medical history. Research figures quoted here come from published studies and are not MOM IVF results.


